Familial combined hyperlipidemia is a polygenic trait.
Gill PK, Hegele RA.
Curr Opin Lipidol. 2022 Apr 1;33(2):126-132. doi: 10.1097/MOL.0000000000000796.
Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E, Farahani N, Mardani R, Taheri F, Taghizadeh H, Gheibihayat SM.
Biochem Genet. 2022 Apr;60(2):453-481. doi: 10.1007/s10528-021-10130-2. Epub 2021 Sep 3.
FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
Bello-Chavolla OY, Kuri-García A, Ríos-Ríos M, Vargas-Vázquez A, Cortés-Arroyo JE, Tapia-González G, Cruz-Bautista I, Aguilar-Salinas CA.
Rev Invest Clin. 2018;70(5):224-236. doi: 10.24875/RIC.18002575.
Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies.
Taghizadeh E, Esfehani RJ, Sahebkar A, Parizadeh SM, Rostami D, Mirinezhad M, Poursheikhani A, Mobarhan MG, Pasdar A.
IUBMB Life. 2019 Sep;71(9):1221-1229. doi: 10.1002/iub.2073. Epub 2019 Jul 4.
Combined hyperlipidemia: familial but not (usually) monogenic.
Brahm AJ, Hegele RA.
Curr Opin Lipidol. 2016 Apr;27(2):131-40. doi: 10.1097/MOL.0000000000000270.
[Familial combined hyperlipidemia: consensus document].
Mata P, Alonso R, Ruíz-Garcia A, Díaz-Díaz JL, González N, Gijón-Conde T, Martínez-Faedo C, Morón I, Arranz E, Aguado R, Argueso R, Perez de Isla L.
Aten Primaria. 2014 Oct;46(8):440-6. doi: 10.1016/j.aprim.2014.04.013. Epub 2014 Jul 14.
Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
Lee JC, Lusis AJ, Pajukanta P.
Curr Opin Lipidol. 2006 Apr;17(2):101-9. doi: 10.1097/01.mol.0000217890.54875.13.
Familial combined hyperlipidemia: from molecular insights to tailored therapy.
van Greevenbroek MM, Stalenhoef AF, de Graaf J, Brouwers MC.
Curr Opin Lipidol. 2014 Jun;25(3):176-82. doi: 10.1097/MOL.0000000000000068.
Genetics of familial combined hyperlipidemia.
Naukkarinen J, Ehnholm C, Peltonen L.
Curr Opin Lipidol. 2006 Jun;17(3):285-90. doi: 10.1097/01.mol.0000226121.27931.3f.
Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA, Zamora M, Gómez-Díaz RA, Mehta R, Gómez Pérez FJ, Rull JA.
Semin Vasc Med. 2004 May;4(2):203-9. doi: 10.1055/s-2004-835379.
